Drug Profile
Research programme: dendritic cell vaccine - NEMOD
Alternative Names: NemodDCLatest Information Update: 15 Feb 2008
Price :
$50
*
At a glance
- Originator NEMOD Biotherapeutics [CEASED]
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 06 Apr 2006 No development reported - Preclinical for Cancer in Germany (unspecified route)
- 23 Aug 2004 NemodDC™ is available for co-development and licensing (http://www.nemod.com)
- 15 Aug 2003 Preclinical trials in Cancer in Germany (unspecified route)